Sabby Management, Dara Biosciences: In a new 13G filing just reported to the SEC, Hal Mintz’s Sabby Management reported an 8.3% stake in DARA Biosciences Inc (NASDAQ:DARA) stock. Due to the nature of the disclosure, Sabby is here as a passive investor, much as Alpha Capital Anstalt reported yesterday. At market close, Alpha reported a slightly smaller 7.6% stake in Dara.
Disclosure: none